Motivation: Machine Learning (ML) models have been shown in many cases to achieve higher predictive power than simpler statistical methods [1] . It is therefore easy to envision sophisticated, carefully calibrated ML models being utilized to support critical decision-making as in, e.g., [2] , [3] . However, despite their ability to provide accurate predictions, ML models have not been heavily utilized in fields such as medicine and prognostic research [4] [5] [6] .
One reason for this is the inherent complexity of black-box ML models like neural networks. Such models are powerful because of their ability to detect complex patterns in data, achieving high predictive accuracy. However, this makes them difficult to explain to non-experts in less technical fields. Users wishing to leverage predictive models for critical decision-making, such as medical risk prognosis, must be professionally and ethically able to justify their medical actions, explicitly linking inputs like patient characteristics to predicted outcomes [7] . Existing neural networks and other ML models do not readily provide for this. As a result, the ML research community has been paying increased attention to interpretability. We define ML model interpretability as the extent to which a ML model can be made understandable to relevant human users, with the goal of increasing users' trust in, and willingness to utilize, the model in practice. We argue that this focus on trustworthiness has been neglected from past literature but is absolutely vital -a comprehensible model is not useful unless it is also trusted.
A recent survey compiled an overview of methods used to explain black-box ML models [8] . To date, most research on ML interpretability focuses on developing methods we term interpretability modules, which run alongside existing black-box models to produce statistical explanations that are generally accepted as being easily understandable to humans. These methods range from ranking input features' contributions to generating entirely new models that closely approximate the original black-box while using a simpler, supposedly easier-to-understand methodology such as linear regression (e.g., LIME [9] , SLIM [10] ), decision-trees [11] or logic rules [12] .
These studies rely on important assumptions. First, it is assumed that feature rankings, linear models, or decision-trees are indeed interpretable, and that they consistently increase the utility of ML models for clinical users. This assumption appears overly simplistic -it is likely that interpretability is subjective, requiring different approaches for different users and in different contexts. Secondly, it is assumed that simply presenting the modules is enough to achieve interpretability. We argue that this is not enough: instead, interpretable systems require a user-in-the-loop design approach based on an interactive process enabling designers to convince people to trust and utilize ML-driven systems.
Limited work has investigated these assumptions and how different types of ML model evidence actually affect users' trust [13] [14] . Our work differs from these recent efforts as we propose to use Reinforcement Learning (RL) to present different methods of interpretability and thus learn what is effectively interpretable to different users and, consequently, build their trust in ML models.
Contributions:
We first train a neural network to provide risk assessments for heart failure patients. We then design a RL-based clinical decision-support system (DSS) around the neural network model. The DSS presents a sequence of interpretability modules and other forms of evidence about the underlying ML model to the user (e.g., information about the data-set, training methodology, and model accuracy, in addition to interpretability modules including local linear and decision-tree approximations). As users interact with the DSS, it learns to present an information sequence that maximizes users' expected trust in the ML model using RL. We asked 14 clinicians 1 and 30 ML experts from multiple institutions and countries to interact with our DSS. Clinicians rated their trust in the ML model as they used the system, while ML experts indicated if they believe that the presented information would increase the average clinician's trust in the ML model. Our results lead to new findings that may have broad implications for the future of ML interpretability.
